Trial intelligence / Profile preview

Lactate for Brain Metabolism in Acute Ischemic Stroke

NCT04858139Phase 2Terminated

Sponsor
Lausanne University Hospital
Start
Aug 2021
Primary completion
Mar 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of lactate in ischemic stroke, sponsored by Lausanne University Hospital. Started Aug 2021; status: terminated.

02

Drugs

lactate
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT04858139.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04858139.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call